SCHEMBL21691666

SCHEMBL21691666

N#Cc1c(-c2ccccc2)cc(-c2cccc3c2sc2ccccc23)cc1-c1ccc2sc3ccccc3c2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.51
PRKDC P78527 1/20 0.37
SQOR Q9Y6N5 3/20 0.35
PARP14 Q460N5 1/20 0.35
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
F9 P00740 1/20 0.34
ADORA1 P30542 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ADORA2A P29274 1/20 0.34
MAPK1 P28482 1/20 0.34
LIMK1 P53667 3/20 0.33
ATM Q13315 1/20 0.33
GPR3 P46089 1/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PIM1 P11309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21692216 0.93 ALOX5 (0.47) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21693127 0.93 ALOX5 (0.51) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21693098 0.92 ALOX5 (0.48) ALOX5PRKDCPARP14ADORA1ADORA2A
SCHEMBL21692376 0.92 ALOX5 (0.47) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21691697 0.92 ALOX5 (0.44) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21691701 0.92 ALOX5 (0.47) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21691596 0.91 SQOR (0.39) ALOX5SQORF9ADORA1L3MBTL1
SCHEMBL21693073 0.90 ALOX5 (0.49) ALOX5PRKDCSQORPARP14TNKS
SCHEMBL21693097 0.90 ALOX5 (0.48) ALOX5PRKDCPARP14TNKSTNKS2
SCHEMBL21692225 0.89 SQOR (0.39) ALOX5SQORADORA1L3MBTL1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885PRKDC 4839/4885SQOR 3254/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885PRKDC 4839/4885SQOR 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.